This tender is from the country of Albania in Europe region. The tender was published by Durres regional hospital directorate on 18 Aug 2025 for Loti 2-human rabies immunoglobulin. The last date to submit your bid for this tender was 25 Aug 2025. This tender is for the companies specializing in Immune sera and immunoglobulins, Immunoglobulins, Typhus vaccines and similar sectors.
*The deadline for this tender has passed.
Tender Organisation:
Durres regional hospital directorate
Tender Sector:
Tender Service:
Worldwide
Tender Region:
Tender Country:
Tender CPV:
33651500 : Immune sera and immunoglobulins
33651520 : Immunoglobulins
33651650 : Typhus vaccines
Tender Document Type:
Tender Notice
Tender Description:
Loti 2-human rabies immunoglobulin
Tender Bidding Type:
Tender Notice No:
Tender Document:
Looking for more tenders like this one in Immune sera and immunoglobulins, Immunoglobulins, Typhus vaccines? With over 70 million global procurement opportunities and new tenders added daily, Tender Impulse is your gateway to international and local contracting success. Whether you're targeting the Defence sector in Albania, or expanding across regions, we provide live, accurate, and relevant updates every day.
Our platform sources tenders from:
Every day, we add hundreds of new RFPs, RFQs, EOIs, and contract awards across multiple sectors and geographies. This tender from Albania is just a sample of what's available right now.
Tender Impulse covers:
Each listing is categorized using CPV codes like 33651500, 33651520, 33651650, enabling precise filtering. Search by:
While you're viewing a tender in Albania, Tender Impulse offers access to tenders across:
Tender Impulse provides more than listings:
Thousands of new tenders are added daily-across countries, sectors, and CPV codes. With Tender Impulse, you gain strategic insight, timely alerts, and a competitive edge.
Start your free trial to unlock tenders customized to your Defence, Albania, and Immune sera and immunoglobulins, Immunoglobulins, Typhus vaccines categories.